October 2009 Volume 16 Number 10, pp 1175 - 1282
--------------------------------------------------------------------------
JHG Editor's Choice:
Innovative genetic advancement
Journal of Human Genetics (JHG) is proud to feature Editor's Choice:
Innovative genetic advancement - an original collection of articles and
reviews on the most recent, important developments in the field. This
web focus features a variety of articles covering:
- The first genome-wide association study
- Disease susceptibility genes
- Towards personalized medicine
- Population specificity and genome diversity
Access this limited-time web focus today!
http://links.ealert.nature.com/ctt?kn=27&m=34296680&r=MTc2MTA1MzIyNwS2&b=2&j=NTk2Njg4MzcS1&mt=1&rt=0
--------------------------------------------------------------------------
Advance Online Publication
http://links.ealert.nature.com/ctt?kn=33&m=34296680&r=MTc2MTA1MzIyNwS2&b=2&j=NTk2Njg4MzcS1&mt=1&rt=0
Articles for this journal are published online ahead of print
through Advance Online Publication (AOP), meaning that the latest
research reaches you in the timeliest way possible. Check the AOP
webpage each week to make sure that you are not left behind:
http://links.ealert.nature.com/ctt?kn=33&m=34296680&r=MTc2MTA1MzIyNwS2&b=2&j=NTk2Njg4MzcS1&mt=1&rt=0
----------------------
NEWS AND COMMENTARIES
----------------------
A fine balance: an autoregulatory gene therapy approach to treat obesity
and achieve energy homeostasis
S L Samson, M Kohjima and L Chan
http://links.ealert.nature.com/ctt?kn=34&m=34296680&r=MTc2MTA1MzIyNwS2&b=2&j=NTk2Njg4MzcS1&mt=1&rt=0
Stem cells, ribozymes and HIV
J C Burnett and J J Rossi
http://links.ealert.nature.com/ctt?kn=31&m=34296680&r=MTc2MTA1MzIyNwS2&b=2&j=NTk2Njg4MzcS1&mt=1&rt=0
----------------------
PROGRESS AND PROSPECTS: REVIEW ARTICLE
----------------------
Progress and prospects: human artificial chromosomes
S Macnab and A Whitehouse
Abstract: http://links.ealert.nature.com/ctt?kn=40&m=34296680&r=MTc2MTA1MzIyNwS2&b=2&j=NTk2Njg4MzcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=38&m=34296680&r=MTc2MTA1MzIyNwS2&b=2&j=NTk2Njg4MzcS1&mt=1&rt=0
Engineering ligand-responsive gene-control elements: lessons learned from
natural riboswitches
K H Link and R R Breaker
Abstract: http://links.ealert.nature.com/ctt?kn=37&m=34296680&r=MTc2MTA1MzIyNwS2&b=2&j=NTk2Njg4MzcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=36&m=34296680&r=MTc2MTA1MzIyNwS2&b=2&j=NTk2Njg4MzcS1&mt=1&rt=0
----------------------
ORIGINAL ARTICLES
----------------------
Efficient, glucose responsive and islet-specific transgene expression by
a modified rat insulin promoter
R Chai, S Chen, J Ding and P A Grayburn
Abstract: http://links.ealert.nature.com/ctt?kn=44&m=34296680&r=MTc2MTA1MzIyNwS2&b=2&j=NTk2Njg4MzcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=43&m=34296680&r=MTc2MTA1MzIyNwS2&b=2&j=NTk2Njg4MzcS1&mt=1&rt=0
Immunological priming potentiates non-viral anti-inflammatory gene therapy
treatment of neuropathic pain
E Sloane, S Langer, B Jekich, J Mahoney, T Hughes, M Frank, W Seibert, G
Huberty, B Coats, J Harrison, D Klinman, S Poole, S Maier, K Johnson, R
Chavez, L R Watkins, L Leinwand and E Milligan
Abstract: http://links.ealert.nature.com/ctt?kn=49&m=34296680&r=MTc2MTA1MzIyNwS2&b=2&j=NTk2Njg4MzcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=50&m=34296680&r=MTc2MTA1MzIyNwS2&b=2&j=NTk2Njg4MzcS1&mt=1&rt=0
Lister strain of vaccinia virus armed with endostatin-angiostatin fusion
gene as a novel therapeutic agent for human pancreatic cancer
J R Tysome, A Briat, G Alusi, F Cao, D Gao, J Yu, P Wang, S Yang, Z Dong,
S Wang, L Deng, J Francis, T Timiryasova, I Fodor, N R Lemoine and Y Wang
Abstract: http://links.ealert.nature.com/ctt?kn=52&m=34296680&r=MTc2MTA1MzIyNwS2&b=2&j=NTk2Njg4MzcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=53&m=34296680&r=MTc2MTA1MzIyNwS2&b=2&j=NTk2Njg4MzcS1&mt=1&rt=0
Intrathecal transplantation of human neural stem cells overexpressing VEGF
provide behavioral improvement, disease onset delay and survival extension
in transgenic ALS mice
D H Hwang, H J Lee, I H Park, J I Seok, B G Kim, I S Joo and S U Kim
Abstract: http://links.ealert.nature.com/ctt?kn=55&m=34296680&r=MTc2MTA1MzIyNwS2&b=2&j=NTk2Njg4MzcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=57&m=34296680&r=MTc2MTA1MzIyNwS2&b=2&j=NTk2Njg4MzcS1&mt=1&rt=0
CR1/2 is an important suppressor of Adenovirus-induced innate immune
responses and is required for induction of neutralizing antibodies
S S Seregin, Y A Aldhamen, D M Appledorn, N J Schuldt, A J McBride,
M Bujold, S S Godbehere and A Amalfitano
Abstract: http://links.ealert.nature.com/ctt?kn=56&m=34296680&r=MTc2MTA1MzIyNwS2&b=2&j=NTk2Njg4MzcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=61&m=34296680&r=MTc2MTA1MzIyNwS2&b=2&j=NTk2Njg4MzcS1&mt=1&rt=0
Transcriptional IL-15-directed in vivo DC targeting DNA vaccine
S Tian, Z Liu, C Donahue, H S Noh, L D Falo and Z You
Abstract: http://links.ealert.nature.com/ctt?kn=59&m=34296680&r=MTc2MTA1MzIyNwS2&b=2&j=NTk2Njg4MzcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=62&m=34296680&r=MTc2MTA1MzIyNwS2&b=2&j=NTk2Njg4MzcS1&mt=1&rt=0
An immobilized nanoparticle-based platform for efficient gene knockdown of
argeted cells in the circulation
Z Huang and M R King
Abstract: http://links.ealert.nature.com/ctt?kn=21&m=34296680&r=MTc2MTA1MzIyNwS2&b=2&j=NTk2Njg4MzcS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=23&m=34296680&r=MTc2MTA1MzIyNwS2&b=2&j=NTk2Njg4MzcS1&mt=1&rt=0
--------------------------------------------------------------------------
Molecular Therapy is accepting submissions!
Featuring author benefits like ZERO submission fees, Advanced Online Publication (AOP)
http://links.ealert.nature.com/ctt?kn=25&m=34296680&r=MTc2MTA1MzIyNwS2&b=2&j=NTk2Njg4MzcS1&mt=1&rt=0
and inclusion in abstracting and indexing services like ISI, MEDLINE and EMBASE.
Molecular Therapy is the only journal ranked within the top 20th percentile in biotechnology,
genetics and medicine.
To learn more about publishing in Molecular Therapy visit
http://links.ealert.nature.com/ctt?kn=5&m=34296680&r=MTc2MTA1MzIyNwS2&b=2&j=NTk2Njg4MzcS1&mt=1&rt=0
=====================================================================
You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://links.ealert.nature.com/ctt?kn=35&m=34296680&r=MTc2MTA1MzIyNwS2&b=2&j=NTk2Njg4MzcS1&mt=1&rt=0
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne - San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.
© Copyright 2009 Nature Publishing Group
=====================================================================
